Melatonin, Endogenous hormone agonist at MT1 and MT2 receptors

Be the first to review this product! Submit a review

|

(1 Publication)

MW 232.28 Da, Purity >99%. Agonist at melatonin MT1 and MT2 receptors. Endogenous hormone important in the control of the circadian rhythm. Wide range of pathophysiological functions including antioxidative and immunomodulatory effects.

View Alternative Names

1,8-cineole 2-exo-monooxygenase, AHR_HUMAN, Ah receptor, Albendazole monooxygenase, Albendazole sulfoxidase, Aromatic hydrocarbon receptor, Aryl hydrocarbon hydroxylase, Aryl hydrocarbon receptor, Aryl hydrocarbon receptor precursor, Atherosclerosis, susceptibility to, included, BXR, CP 12, CP1A2_HUMAN, CP1B, CP1B1_HUMAN, CP33, CP34, CP3A4_HUMAN, CYP1A2, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIA2, CYPIB1, CYPIIIA3, CYPIIIA4, Class E basic helix-loop-helix protein 76, Cytochrome P(3)450, Cytochrome P450 1A2, Cytochrome P450 1B1, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 4, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450 family 1 polypeptide 2, Cytochrome P450 family 1 subfamily A polypeptide 2, Cytochrome P450 family 1 subfamily B polypeptide 1, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily I (dioxin inducible) polypeptide 1 (glaucoma 3 primary infantile), Cytochrome P450 subfamily I aromatic compound inducible polypeptide 2, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450-P3, Cytochrome P450-PCN1, DHQV, DIA6, DKFZp686N23123, Dioxin inducable P3 450, EC 1.10.99.2, ER, ER-alpha, ER-beta, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESTR B, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen resistance, included, FGQTL2, GLC3A, Glucocorticoid inducible P450, HDL cholesterol, augmented response of, to hormone replacement, included, HGNC:348, HLP, MEL-1A-R, MEL-1B-R, MGC126680, MGC94180, MR, MT 2 melatonin receptor, MT-1, MTNR 1A, MTR1A_HUMAN, MTR1B_HUMAN, Mel 1b, Mel 1b melatonin receptor, Mel1a melatonin receptor, Mel1a receptor, Mel1b receptor, MelR, Melatonin receptor 1A, Melatonin receptor MEL 1B, Melatonin receptor type 1A, Melatonin receptor type 1B, Microsomal monooxygenase, Mtnr 1b, Myocardial infarction, susceptibility to, included, NAD(P)H dehydrogenase quinone 2, NAD(P)H menadione oxidoreductase 1 dioxin inducible 2, NAD(P)H menadione oxidoreductase 2 dioxin inducible, NF 25, NMOR2, NQO2_HUMAN, NR1I2_HUMAN, NR3A1, NR3A2, NRH dehydrogenase, NRH dehydrogenase [quinone] 2, NRH:quinone oxidoreductase 2, Nifedipine oxidase, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, ONR 1, OTTHUMP00000015948, OTTHUMP00000015949, OTTHUMP00000015953, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, Ox 2, P(3)450, P3 450, P450 4, P450 III steroid inducible, P450 P3, P450 PCN1, P450 form 4, P450(PA), P450, family III, P4501B1, P450C3, PAR, PAR q, PRR, Pregnane X receptor, QR2, Quinine 3-monooxygenase, Quinone, Quinone reductase 2, RNESTROR, Ribosyldihydronicotinamide dehydrogenase, Ribosyldihydronicotinamide dehydrogenase [quinone], SXR, Steroid and xenobiotic receptor, Taurochenodeoxycholate 6-alpha-hydroxylase, Xenobiotic monooxygenase, bHLHe76, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4, flavoprotein-linked monooxygenase, melatonin receptor 1B, pregnane X nuclear receptor variant 2